These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12169379)

  • 1. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India.
    Coyaji K; Elul B; Krishna U; Otiv S; Ambardekar S; Bopardikar A; Raote V; Ellertson C; Winikoff B
    Contraception; 2002 Jul; 66(1):33-40. PubMed ID: 12169379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days.
    Schaff EA; Fielding SL; Eisinger SH; Stadalius LS; Fuller L
    Contraception; 2000 Jan; 61(1):41-6. PubMed ID: 10745068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can women in less-developed countries use a simplified medical abortion regimen?
    Elul B; Hajri S; Ngoc NN; Ellertson C; Slama CB; Pearlman E; Winikoff B
    Lancet; 2001 May; 357(9266):1402-5. PubMed ID: 11356438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea.
    Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS
    Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone abortion outside the urban research hospital setting in India.
    Coyaji K; Elul B; Krishna U; Otiv S; Ambardekar S; Bopardikar A; Raote V; Ellertson C; Winikoff B
    Lancet; 2001 Jan; 357(9250):120-2. PubMed ID: 11197403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial.
    Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L
    JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
    Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
    Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
    Warden S; Genkin I; Hum S; Dunn S
    J Obstet Gynaecol Can; 2019 May; 41(5):647-652. PubMed ID: 31007171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic Review of the Effectiveness, Safety, and Acceptability of Mifepristone and Misoprostol for Medical Abortion in Low- and Middle-Income Countries.
    Ferguson I; Scott H
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1532-1542.e2. PubMed ID: 32912726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early medical abortion in India: three studies and their implications for abortion services.
    Coyaji K
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):191-4. PubMed ID: 10846337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study.
    Nisand I; Bettahar K;
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability and feasibility of medical abortion in Nepal.
    Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
    Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center.
    Mundle S; Elul B; Anand A; Kalyanwala S; Ughade S
    Contraception; 2007 Jul; 76(1):66-70. PubMed ID: 17586140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.